Publikationen von S. H. E. Kaufmann
Alle Typen
Zeitschriftenartikel (685)
2017
Zeitschriftenartikel
47, S. 8 - 16 (2017)
BCG — old workhorse, new skills. Current Opinion in Immunology
Zeitschriftenartikel
16 (8), S. 845 - 853 (2017)
Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers. Expert Review of Vaccines
Zeitschriftenartikel
17 (6), S. 341 - 343 (2017)
Emil von Behring: translational medicine at the dawn of immunology. Nature Reviews Immunology
Zeitschriftenartikel
56, S. 263 - 267 (2017)
Novel approaches to tuberculosis vaccine development. International journal of infectious diseases
Zeitschriftenartikel
56, S. 258 - 262 (2017)
High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers. International journal of infectious diseases
Zeitschriftenartikel
8 (1), e00117-17 (2017)
Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes. mBio
Zeitschriftenartikel
24 (2), e00439-16 (2017)
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa. Clinical and Vaccine Immunology
Zeitschriftenartikel
12 (1), e0169119 (2017)
Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis. PLoS One
Zeitschriftenartikel
2017 (1), S. 24 - 28 (2017)
Tuberkulose: Vergessen, aber nicht besiegt. Warum? Trillium Immunologie 2016
Zeitschriftenartikel
6, 39097 (2016)
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants. Scientific Reports
Zeitschriftenartikel
18 (12), S. 1846 - 1856 (2016)
Syndecans promote mycobacterial internalization by lung epithelial cells. Cellular Microbiology
Zeitschriftenartikel
7 (6), e01686-16 (2016)
Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis. mBio
Zeitschriftenartikel
20 (5), S. 584 - 595 (2016)
The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation. Cell Host & Microbe
Zeitschriftenartikel
46 (11), S. 2574 - 2586 (2016)
Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. European Journal of Immunology
Zeitschriftenartikel
8 (11), S. 1325 - 1339 (2016)
Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis. EMBO Molecular medicine
Zeitschriftenartikel
11 (10), e0165853 (2016)
Correction: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis. PLoS One
Zeitschriftenartikel
17 (1), 837 (2016)
Developmental transcriptome of resting cell formation in Mycobacterium smegmatis. BMC Genomics
Zeitschriftenartikel
84 (10), S. 2914 - 2921 (2016)
Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis. Infection and Immunity
Zeitschriftenartikel
11 (9), e0163662 (2016)
The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis. PLoS One
Zeitschriftenartikel
73 (3), S. 219 - 230 (2016)
Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease. Journal of infection